Reviva Pharmaceuticals Holdings, Inc. Current Assets
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Current Assets of $21.14 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-12
- 2026-06-30: Assets, Current $21.14M.
- 2026-03-31: Assets, Current $23.56M.
- 2025-12-31: Assets, Current $15.10M.
- 2025-09-30: Assets, Current $13.51M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $21.14M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $23.56M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $15.10M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $13.51M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $10.82M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $6.26M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $14.68M 10-K · filed 2026-03-30 |
| 2024-09-30 | $6.81M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $7.23M 10-Q · filed 2024-08-14 |
| 2023-12-31 | $23.70M 10-K · filed 2025-04-03 |
| 2020-11-30 | $44.21K 10-Q · filed 2021-01-14 |
| 2020-08-31 | $38.11K 10-Q · filed 2020-10-14 |
| 2020-05-31 | $239.69K 10-Q · filed 2020-07-07 |
| 2020-02-29 | $138.86K 10-Q · filed 2021-01-14 |
| 2019-11-30 | $149.96K 10-Q · filed 2020-01-10 |
| 2019-08-31 | $249.81K 10-Q · filed 2019-10-08 |
| 2019-05-31 | $337.68K 10-Q · filed 2019-07-03 |
| 2019-02-28 | $404.18K 10-K · filed 2020-05-04 |
| 2018-11-30 | $461.51K 10-Q · filed 2019-01-09 |
| 2018-08-31 | $519.77K 10-Q · filed 2018-10-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |